Devices › Device types
FDA product code FED · class 2 · Gastroenterology, Urology
Endoscopic access overtube, gastroenterology-urology: medical device reports filed with FDA
1,322 reports carry this product code, 1995–2026; 5 brands with a page.
- 1,322
- reports with this product code
- 0% of all MAUDE reports
- 111
- reports, 12 months to August 2026
- 96 in the 12 months before
- 72.1%
- classified as malfunction
- 62.3% across all reports
- 1.7%
- classified as death, as reported
- 0.9% across all reports
Product code FED is FDA's classification for "Endoscopic access overtube, gastroenterology-urology" (gastroenterology, Urology panel), a class 2 device. 1,322 medical device reports carry this product code, 0% of the MAUDE database, from June 1995 to August 2026.
111 reports arrived in the 12 months to August 2026, up 16% from 96 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (72.1%), injury (18.9%) and other (5.2%). 5 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Navigator Hd | 150 | 3 | 0.6% | 71.1% |
| Karl Storz | 34 | 0 | 2.1% | 24.6% |
| Inner sheath, for 26 Fr. outer sheath | 12 | 533 | 0% | 90.9% |
| Resection sheath, 24 Fr. | 11 | 170 | 0.1% | 88.4% |
| Olympus | 1 | 9 | 2.5% | 69.7% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Olympus Winter & Ibe | 84 | 6.4% |
| Ethicon | 50 | 3.8% |
| Gyrus Acmi | 24 | 1.8% |
| Richard Wolf | 15 | 1.1% |
| Coloplast A/S | 13 | 1% |
| Keymed Medical And Industrial Equipment | 13 | 1% |
| Olympus Medical Systems Hinode Plant | 11 | 0.8% |
| Apollo Endosurgery | 10 | 0.8% |
| Applied Medical Resources | 8 | 0.6% |
| Applied Medical | 5 | 0.4% |
| C R Bard Covington | 1 | 0.1% |
| Medtronic Xomed | 1 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Tip breakage | 257 | 19.4% |
| Breakthe device broke | 208 | 15.7% |
| Detachment of device component | 128 | 9.7% |
| Peeled/delaminated | 84 | 6.4% |
| Difficult to insertthe device was hard to insert | 63 | 4.8% |
| Material separation | 54 | 4.1% |
| Material split, cut or torn | 51 | 3.9% |
| Device, or device fragments remain in patient | 48 | 3.6% |
| Difficult to removethe device was hard to remove | 36 | 2.7% |
| Replace | 35 | 2.6% |
| Component(s), broken | 30 | 2.3% |
| Detachment of device or device componentpart of the device came off | 30 | 2.3% |
| Device contamination with chemical or other material | 30 | 2.3% |
| Device, removal of (non-implant) | 29 | 2.2% |
| Material integrity problema problem with the device material | 27 | 2% |
| Component falling | 23 | 1.7% |
| Material deformation | 20 | 1.5% |
| Material fragmentation | 19 | 1.4% |
| Unsealed device packaging | 19 | 1.4% |
| Insufficient device problem information | 17 | 1.3% |
Questions about endoscopic access overtube, gastroenterology-urology reports
What is product code FED?
FDA's classification code for "Endoscopic access overtube, gastroenterology-urology", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,322 reports through August 2026, 111 of them in the latest 12 months.
Which brands appear most often?
Navigator Hd (150), Karl Storz (34), Inner sheath, for 26 Fr. outer sheath (12), Resection sheath, 24 Fr. (11) and Olympus (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.